|
09-10-2010, 03:47 AM
|
|||
|
|||
Provenge Approval a Boon for Other Cancer Vaccines, Report Says
NEW YORK, NY--(Marketwire - September 9, 2010) - The approval of Dendreon's prostate cancer vaccine Provenge in April was a boon for a nascent cancer vaccine industry that had suffered several setbacks, and should lead to an influx of market opportunities and a surge in regulatory activity, according to Kalorama Information. In its newly published report, "Emerging Cancer Vaccines: Forecasts ...
    
|
 |
| Thread Tools | |
| Display Modes | |
|
|
Similar Threads
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Tanning tax could mean boon for spray tanners | cancerfr | Melanoma | 0 | 08-04-2010 06:54 AM |
| Provenge Nod Bodes Well, but No Free Pass for Cancer Vaccines | cancerfr | Bladder Cancer | 0 | 05-03-2010 06:10 PM |
| Dendreons Provenge Approval Sparks New Era for Cancer Vaccines | cancerfr | Melanoma | 0 | 04-30-2010 06:17 AM |
| Dirty Bomb Research a Boon to Cancer Care? | cancerfr | Bone Cancer | 0 | 04-26-2010 11:14 PM |
| Cancer Non-Hodgkin Lymphoma Therapy Area Pipeline Report - New Market Report Publishe | cancerfr | Non-Hodgkin Lymphoma | 0 | 04-19-2010 10:28 PM |
Linear Mode
